← Leaderboards
Christine E Mona
University Of California Los Angeles
$762,391
Attributed
$2,084,687
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $989.2K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,084,687 · 2
By mechanism
R01$1,679,715 · 1
R21$404,972 · 1
Top collaborators
- Johannes Czernin3 shared
- Caius Gabriel Radu3 shared
- Evan Robert Abt1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Hsian-Rong Tseng$15,333,457
- David T Wong$54,826,713
- Vatche Agopian$3,720,225
- Guido Erwin Michael Eibl$7,914,971
- Arjun Deb$19,563,654
Others in their field
Other Rising Stars on “Prostate Cancer Model”
- Mirabela Rusu · Stanford University$2,887,122
- Remi Adelaiye-Ogala · State University Of New York At Buffalo$2,864,216
- Rajesh Krishnan · Oncternal Therapeutics, Inc.$2,834,010
- Akash Patnaik · University Of Chicago$2,630,502
- Grinu Mathew · University Of Nebraska Medical Center$2,591,510
- Megan K Ruhland · Oregon Health & Science University$2,265,578
Research focus
Prostate Cancer ModelResponseMediatingProductionImmuneResistanceInterferonsMalignant NeoplasmsMouse ModelPre-Clinical ModelFolh1 GeneGeneticAntigen TargetingRadiopharmaceuticalsCombined Modality TherapyImmunocompetentInterferon Type ILinkDna DamageCyclic GmpNeoplastic CellPharmacologicEngineeringSignal Transduction
Grant awards (4)
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC$584,235
R01 · FY2025 · CA
Targeting tumor microenvironment-mediated radiopharmaceutical therapy resistance in prostate cancer$404,972
R21 · FY2025 · CA
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC$567,087
R01 · FY2024 · CA
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC$528,393
R01 · FY2023 · CA